Table 1
From: High preterm delivery rates associated with initiation of HAART during pregnancy
Treatment | Number | Median CD4 /μL (Baseline ANC) | Median HIV viral load/ml | PTD Number (%) |
|---|---|---|---|---|
Zidovudine monotherapy | 61 | 445 | 2513 | 4 (6.6%) |
START | 64 | 360 | 8930 | 16 (25%) |
new continuous HAART | 58 | 150 | 23430 | 10 (17.2%) |
pre-conception HAART | 127 | 385 | 49 | 16 (12.6%) |